Chemed (CHE) Stock: Buy, Sell, or Hold?
CHE - Chemed Corporation
$512.19
-7.96 (-1.53%)
▼
5d:
-0.04%
30d:
+3.34%
90d:
+0.56%
HOLD
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Oct 27, 2026
3d
Get Alerted When CHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CHE is fairly valued with market pricing in 3.2% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: CHE is fairly valued with market pricing in 3.2% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$631.63
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$392.19
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CHE is currently trading at $512.19, which is considered slightly high relative to its 30-day fair value range of $500.68 to $513.71. The stock's valuation (Forward PE: 18.9) is in line with its historical norms (17.2). At these levels, the market is pricing in 3.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CHE is in a uptrend. The price is approaching resistance at $522.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CHE is in a uptrend. The price is approaching resistance at $522.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$500.68 -
$513.71
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.4%
All Signals
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($571.60)
- NEUTRAL: Market pricing in 3.2% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (44/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$500.68 -
$513.71
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$496.79
Resistance Level
$522.59
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.90
Wall Street Target
$571.60
(+9.9%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
43.7%
Profit Margin
10.6%
Valuation Premium vs History
+3.2% premium
PE vs Historical
18.9 vs 17.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.2%
(market-implied from PE analysis)
1-Year Target
$536.79
(+3%)
2-Year Target
$553.97
(+7%)
3-Year Target
$571.70
(+10%)
3-Yr Target (if PE normalizes)
(PE: 19→17)
PE COMPRESSION
$520.21
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 7.9%)
$687.28
(+32%)
Base:
(SPY PE: 18.9, Growth: 7.9%)
$654.14
(+26%)
Bear:
(PE: 16.1, Growth: 7.9%)
$556.02
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 25.72 | Current EPS (TTM): $19.88
Bull Case
$778.62
(+50%)
Analyst growth 38.4%, PE expands to 28.3
Base Case
$707.84
(+36%)
Market implied 38.4%, PE stable at 25.7
Bear Case
$347.73
(-33%)
Severe decline -20.0%, PE contracts to 21.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 23, 2026 2:42 PM ET
Data refreshes hourly during market hours. Next update: 3:42 PM
Data refreshes hourly during market hours. Next update: 3:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$286 | 51 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 49 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 61 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 50 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
14 analysts |
$134 | 54 HOLD |